Ultimed Pharma Private Limited
About Ultimed Pharma Private Limited
Data last updated:
Ultimed Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 June 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2008PTC184129. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Deepak Harjivandas Gandhi and Bharat Harjivandas Gandhi.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 20/24 Old Hanuman Lane 4th Floor Office No. 52, Mumbai, Maharashtra, India – 400002.
As per the financials filed for FY 2021, the company reported a revenue of ₹43,503, a decline of 92% compared to the previous year. For the same year it recorded a net loss of ₹85,436 (net margin -196.4%) and EBITDA of -₹55,168 (EBITDA margin -126.8%). Revenue has declined at a compounded annual rate (CAGR) of 91% over three years and 80% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address20/24 Old Hanuman Lane 4th Floor Office No. 52, Mumbai, Maharashtra, India – 400002
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Ultimed Pharma Private Limited FY 2021 filings available
Ultimed Pharma Private Limited reported revenue of ₹43,503 (down 92% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR) of Ultimed Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 80% over five years, including a 92% fall in the latest year. EBITDA fell 115% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ultimed Pharma Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹55,168 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹85,436 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ultimed Pharma Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -126.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -196.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ultimed Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ultimed Pharma Private Limited
Ultimed Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fagris Medica Private Limieted | ₹45,181 (FY 2020) | •••• | •••• | -95.0% | •••• | Navi Mumbai, Maharashtra, India |
| Pharma Fine Chemical Industries Private Limited | ₹44,915 (FY 2024) | •••• | •••• | 10.0% | •••• | Begusarai, Bihar, India |
| Tusya Ayurvedic Private Limited | ₹44,625 (FY 2022) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Poonawalla Biotech Private Limited | ₹44,250 (FY 2025) | •••• | •••• | •••• | Pune, Maharashtra, India | |
| Goodhealth Holdings Private Limited | ₹44,000 (FY 2025) | •••• | •••• | •••• | Chennai, Tamil Nadu, India | |
| Ultimed Pharma Private Limited this company | ₹43,503 (FY 2021) | •••• | •••• | -92.0% | •••• | Mumbai, Maharashtra, India |
| DBS Pharma Private Limited | ₹42,900 (FY 2024) | •••• | •••• | -100.0% | •••• | Hyderabad, Telangana, India |
| Alpa Expoim Private Limited | ₹42,390 (FY 2021) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Phages Pharmaceutical Private Limited | ₹42,360 (FY 2024) | •••• | •••• | 20.0% | •••• | Prayagraj, Uttar Pradesh, India |
| Nutech Formulations Private Limited | ₹42,346 (FY 2025) | •••• | •••• | 5.0% | •••• | New Delhi, Delhi, India |
| Protent Pharma Private Limited | ₹42,119 (FY 2025) | •••• | •••• | -3.0% | •••• | Mrg, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Ultimed Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ultimed Pharma Private Limited
Ultimed Pharma Private Limited is audited by DEEPAK S L AGARWAL & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DEEPAK S L AGARWAL & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ultimed Pharma Private Limited
Ultimed Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Harjivandas Gandhi | Director | 30 Jun 2008 | 18 Years 3 Months | Current |
| Bharat Harjivandas Gandhi | Director | 30 Jun 2008 | 18 Years 3 Months | Current |
Ownership and Shareholding of Ultimed Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ultimed Pharma Private Limited
Ultimed Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ultimed Pharma Private Limited
Employment history and EPFO contributions of people linked to Ultimed Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ultimed Pharma Private Limited
Ultimed Pharma Private Limited has 4 board changes on record since 2008: 2 appointments and 2 cessations. The latest: Dilesh Bharat Gandhi ceased to be Director on 02 Dec 2015.
Credit Ratings, Litigation & Regulatory Alerts for Ultimed Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ultimed Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ultimed Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ultimed Pharma Private Limited
Ultimed Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ultimed Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ultimed Pharma Private Limited
Ultimed Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 June 2008 (18+ years old) and is registered under CIN U24239MH2008PTC184129.
Ultimed Pharma reported revenue of ₹43,503 for FY 2021 (down 92% YoY).
Ultimed Pharma has 2 current directors:
- Deepak Harjivandas Gandhi - Director
- Bharat Harjivandas Gandhi - Director
Ultimed Pharma reported a net loss of ₹85,436 (net margin -196.4%) and EBITDA of -₹55,168 (EBITDA margin -126.8%) for FY 2021, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ultimed Pharma is -91% over three years and -80% over five years. In the latest year (FY 2021) revenue fell 92%. CAGR is the steady yearly rate that links the first and the last year.
No. Ultimed Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Ultimed Pharma is U24239MH2008PTC184129. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ultimed Pharma was incorporated on 30 June 2008, making it 18+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Ultimed Pharma by revenue are Fagris Medica Private Limieted, Pharma Fine Chemical Industries Private Limited, Tusya Ayurvedic Private Limited, Poonawalla Biotech Private Limited, Goodhealth Holdings Private Limited and 5 more, all in the Pharma industry (Formulations).
Dilesh Bharat Gandhi ceased to be Director on 02 Dec 2015. Trrushen Deepak Gandhi ceased to be Director on 02 Dec 2015. Bharat Harjivandas Gandhi was appointed as Director on 30 Jun 2008. Ultimed Pharma has 4 board changes on record in total.
The registered office of Ultimed Pharma is at 2024 Old Hanuman Lane 4th Floor Office No. 52, Mumbai, Maharashtra, India – 400002.